Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancer. The Breast, October 2014 [in press]
Dalmau, E., et al.
http://www.thebreastonline.com/article/S0960-9776(14)00171-4/abstract?rss=yes
The natural history of HR+ breast cancer tends to be different from hormone receptor-negative disease in terms of time to recurrence, site of recurrence and overall aggressiveness of the disease.
